COMMUNIQUÉ DE PRESSE publié le 18/01/2024 à 13:00, il y a 7 mois 29 jours Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:00, il y a 8 mois Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
COMMUNIQUÉ DE PRESSE publié le 15/11/2023 à 13:00, il y a 10 mois 1 jour Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
COMMUNIQUÉ DE PRESSE publié le 15/06/2023 à 13:00, il y a 1 année 3 mois OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
COMMUNIQUÉ DE PRESSE publié le 09/05/2023 à 13:00, il y a 1 année 4 mois Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
COMMUNIQUÉ DE PRESSE publié le 04/05/2023 à 13:00, il y a 1 année 4 mois Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
COMMUNIQUÉ DE PRESSE publié le 03/05/2023 à 15:05, il y a 1 année 4 mois Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
COMMUNIQUÉ DE PRESSE publié le 01/05/2023 à 13:00, il y a 1 année 4 mois Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
COMMUNIQUÉ DE PRESSE publié le 30/03/2023 à 13:00, il y a 1 année 5 mois Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
COMMUNIQUÉ DE PRESSE publié le 29/03/2023 à 17:45, il y a 1 année 5 mois Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Publié le 16/09/2024 à 18:00, il y a 3 heures 23 minutes Report on the Combined General Meeting of the 12th of September 2024
Publié le 16/09/2024 à 18:00, il y a 3 heures 23 minutes Compte-rendu d’Assemblée Générale Mixte du 12 septembre 2024
Publié le 16/09/2024 à 18:00, il y a 3 heures 23 minutes Programme de rachat d’actions propres : Déclaration des transactions sur actions propres réalisées du 9 septembre 2024 au 13 septembre 2024
Publié le 16/09/2024 à 18:00, il y a 3 heures 23 minutes Share buy-back program: Disclosure of trading in own shares from 9 September 2024 to 13 September 2024
Publié le 16/09/2024 à 18:00, il y a 3 heures 23 minutes imerys-16-09-2024-communique-capital-droits-de-vote-au-31-juillet-2024
Publié le 16/09/2024 à 21:05, il y a 18 minutes Actor Jeremy Renner Bringing an All-Star Charity Experience to Las Vegas
Publié le 16/09/2024 à 21:00, il y a 23 minutes SHPE, Nation’s Largest Organization of Top Hispanics in Stem, Celebrates 50 Years as It Hosts National Convention & Career Fair in Anaheim, Calif. October 30 - November 3
Publié le 16/09/2024 à 20:15, il y a 1 heure 8 minutes New to the Street's Episode 601 Will Air as Sponsored Programming on Fox Business at 10:30 PM PST, September 16, 2024. This Special Episode Will Feature In-Depth Interviews and Profiles of Industry-Leading Companies Driving Innovation in Their Respective
Publié le 16/09/2024 à 20:07, il y a 1 heure 16 minutes Nexera Provides Update#2 on Delayed Filing of Annual Financial Statements and MD&A and Management Cease Trade Order
Publié le 16/09/2024 à 20:00, il y a 1 heure 23 minutes Lender Market Unveils AI-Powered Financial Advisor Service for Business Owners
Publié le 16/09/2024 à 18:32, il y a 2 heures 51 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 16/09/2024 à 18:19, il y a 3 heures 4 minutes BILENDI: Bilendi dévoile 2 projets basés sur son intelligence artificielle générative BARI présentés au congrès mondial ESOMAR
Publié le 16/09/2024 à 17:59, il y a 3 heures 23 minutes EQS-Adhoc: Airbus reports share buyback transactions 9-13 September 2024
Publié le 16/09/2024 à 16:16, il y a 5 heures 7 minutes Original-Research: Netfonds AG (von Montega AG): Kaufen
Publié le 16/09/2024 à 15:28, il y a 5 heures 55 minutes Form 8.3 - The Vanguard Group, Inc.: International Paper Company